Oakbrook Investments’s Integra LifeSciences IART Stock Holding History

Oakbrook Investments’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,900	Closed	-$460K	–	288
2019 Q4	$460K	Hold	7,900	–	–	0.09%	355
2019 Q3	$475K	Hold	7,900	–	–	0.03%	390
2019 Q2	$441K	Sell	7,900 -100	-1%	-$5.15K	0.03%	418
2019 Q1	$446K	Sell	8,000 -400	-5%	-$20.4K	0.03%	420
2018 Q4	$379K	Sell	8,400 -1,350	-14%	-$74.1K	0.03%	424
2018 Q3	$642K	Buy	+9,750	New	+$606K	0.04%	393

Other funds holding IART

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Oakbrook Investments's IART Position: Q1 2020 in Review

Oakbrook Investments sold out of Integra LifeSciences (IART) in Q1 2020, closing a stake of 7,900 shares — an estimated $460K sold.

Oakbrook Investments first reported a position in IART in Q3 2018 and held it in 6 quarters. The position peaked at $642K in Q3 2018. 258 funds tracked by Wall St. Rank hold IART as of Q1 2020.

Oakbrook Investments reported no remaining Integra LifeSciences position as of Q1 2020 after selling out during the quarter.
Oakbrook Investments sold 7,900 Integra LifeSciences shares in Q1 2020, an estimated $460K.
Oakbrook Investments first reported a position in Integra LifeSciences in Q3 2018 and held it in 6 quarters.
Oakbrook Investments's Integra LifeSciences position peaked at $642K in Q3 2018.
258 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.